Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-09-01
|
| Series: | CPT: Pharmacometrics & Systems Pharmacology |
| Online Access: | https://doi.org/10.1002/psp4.12550 |
| _version_ | 1811285581216350208 |
|---|---|
| author | Daniel Scholes Rosenbloom Ping Zhao Vikram Sinha |
| author_facet | Daniel Scholes Rosenbloom Ping Zhao Vikram Sinha |
| author_sort | Daniel Scholes Rosenbloom |
| collection | DOAJ |
| first_indexed | 2024-04-13T02:46:14Z |
| format | Article |
| id | doaj.art-d1978b0fbe474286b2291904f6220a2e |
| institution | Directory Open Access Journal |
| issn | 2163-8306 |
| language | English |
| last_indexed | 2024-04-13T02:46:14Z |
| publishDate | 2020-09-01 |
| publisher | Wiley |
| record_format | Article |
| series | CPT: Pharmacometrics & Systems Pharmacology |
| spelling | doaj.art-d1978b0fbe474286b2291904f6220a2e2022-12-22T03:06:01ZengWileyCPT: Pharmacometrics & Systems Pharmacology2163-83062020-09-019948148310.1002/psp4.12550Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug PropertiesDaniel Scholes Rosenbloom0Ping Zhao1Vikram Sinha2Quantitative Pharmacology and Pharmacometrics, Pharmacokinetics, Pharmacodynamics, and Drug Metabolism (PPDM) Merck & Co., Inc. Kenilworth New Jersey USAThe Bill & Melinda Gates Foundation Seattle Washington USAQuantitative Pharmacology and Pharmacometrics, Pharmacokinetics, Pharmacodynamics, and Drug Metabolism (PPDM) Merck & Co., Inc. Kenilworth New Jersey USAhttps://doi.org/10.1002/psp4.12550 |
| spellingShingle | Daniel Scholes Rosenbloom Ping Zhao Vikram Sinha Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties CPT: Pharmacometrics & Systems Pharmacology |
| title | Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties |
| title_full | Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties |
| title_fullStr | Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties |
| title_full_unstemmed | Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties |
| title_short | Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties |
| title_sort | initiation of antiviral treatment in sars cov2 modeling viral dynamics and drug properties |
| url | https://doi.org/10.1002/psp4.12550 |
| work_keys_str_mv | AT danielscholesrosenbloom initiationofantiviraltreatmentinsarscov2modelingviraldynamicsanddrugproperties AT pingzhao initiationofantiviraltreatmentinsarscov2modelingviraldynamicsanddrugproperties AT vikramsinha initiationofantiviraltreatmentinsarscov2modelingviraldynamicsanddrugproperties |